• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意义未明的单克隆丙种球蛋白病、多发性骨髓瘤和浆细胞白血病中骨髓T细胞的特征表明,细胞毒性/Th1 T细胞浸润增加,呈现出受限的TCR-Vβ库。

Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.

作者信息

Pérez-Andres Martin, Almeida Julia, Martin-Ayuso Marta, Moro Maria Jesus, Martin-Nuñez Guillermo, Galende Josefina, Hernandez Jose, Mateo Gema, San Miguel Jesus F, Orfao Alberto

机构信息

Cytometry Service, Department of Medicine, University of Salamanca, Salamanca, Spain.

出版信息

Cancer. 2006 Mar 15;106(6):1296-305. doi: 10.1002/cncr.21746.

DOI:10.1002/cncr.21746
PMID:16475149
Abstract

BACKGROUND

The majority of studies published to date regarding the role of the bone marrow (BM) microenvironment in the pathogenesis of monoclonal gammopathies (MG) have focused on the interaction between stroma cells and plasma cells, whereas information concerning the lymphocytes infiltrating the tumor microenvironment is scanty.

METHODS

The authors measured the distribution, TCR-Vbeta repertoire, immunophenotype, and functional characteristics of different subsets of BM T lymphocytes from 61 nontreated patients with MG (30 patients with MG of undetermined significance [MGUS], 27 patients with multiple myeloma [MM], and 4 patients with plasma cell leukemia [PCL]).

RESULTS

The authors found a significantly increased rate of BM infiltration by T cells in all patient groups, at the expense of CD4+CD8- and CD4-CD8- T lymphocytes and both CD4+CD28- and CD8+CD28- cytotoxic/effector T cell subsets, and associated with TCR-Vbeta expansions in both CD4+ and CD8+ BM T cells in the majority of patients with MGUS, MM, and PCL. Moreover, the percentage of T cells secreting interferon (IFN)-gamma was found to be increased (P < or = 0.05) both in CD4+ and CD8+ T cells in MGUS and MM patients, and a higher plasma concentration of IFN-gamma was found in patients with MM. It is interesting to note that a positive correlation was noted between the proportion of CD28- and both the percentage of IFN-gamma-secreting cells and the proportion of expanded TCR-Vbeta lymphocytes within the total BM CD4+ T cells.

CONCLUSIONS

The results of the current study demonstrated an increased infiltration of BM by T cells associated with frequent TCR-Vbeta expansions and a more prominent cytotoxic/Th1 phenotype in all the patient groups studied.

摘要

背景

迄今为止,大多数已发表的关于骨髓(BM)微环境在单克隆丙种球蛋白病(MG)发病机制中作用的研究都集中在基质细胞与浆细胞之间的相互作用,而关于浸润肿瘤微环境的淋巴细胞的信息却很少。

方法

作者检测了61例未经治疗的MG患者(30例意义未明的单克隆丙种球蛋白病[MGUS]患者、27例多发性骨髓瘤[MM]患者和4例浆细胞白血病[PCL]患者)骨髓T淋巴细胞不同亚群的分布、TCR-Vβ谱系、免疫表型和功能特征。

结果

作者发现,所有患者组中T细胞的骨髓浸润率均显著增加,以CD4⁺CD8⁻和CD4⁻CD8⁻T淋巴细胞以及CD4⁺CD28⁻和CD8⁺CD28⁻细胞毒性/效应T细胞亚群为代价,并且在大多数MGUS、MM和PCL患者中,CD4⁺和CD8⁺骨髓T细胞中均存在TCR-Vβ扩增。此外,发现MGUS和MM患者的CD4⁺和CD8⁺T细胞中分泌干扰素(IFN)-γ的T细胞百分比均增加(P≤0.05),并且MM患者的血浆IFN-γ浓度更高。有趣的是,在总骨髓CD4⁺T细胞中,CD28⁻的比例与分泌IFN-γ细胞的百分比以及扩增的TCR-Vβ淋巴细胞的比例之间存在正相关。

结论

本研究结果表明,在所有研究的患者组中,T细胞对骨髓的浸润增加,伴有频繁的TCR-Vβ扩增和更突出的细胞毒性/Th1表型。

相似文献

1
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.意义未明的单克隆丙种球蛋白病、多发性骨髓瘤和浆细胞白血病中骨髓T细胞的特征表明,细胞毒性/Th1 T细胞浸润增加,呈现出受限的TCR-Vβ库。
Cancer. 2006 Mar 15;106(6):1296-305. doi: 10.1002/cncr.21746.
2
T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.多发性骨髓瘤和意义未明的单克隆丙种球蛋白病患者的T细胞库:克隆性CD8 + T细胞扩增在肿瘤负荷低的患者中更常见。
Eur J Immunol. 1997 Sep;27(9):2245-52. doi: 10.1002/eji.1830270919.
3
Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.单克隆丙种球蛋白病患者的骨髓T细胞亚群:与临床分期和疾病状态的相关性
Haematologica. 1997 Jan-Feb;82(1):43-6.
4
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.由多发性骨髓瘤和意义未明的单克隆丙种球蛋白病浆细胞所表达的MICA共刺激帕米膦酸激活的γδ淋巴细胞。
Cancer Res. 2005 Aug 15;65(16):7502-8. doi: 10.1158/0008-5472.CAN-05-0731.
5
[Analyses of subset, activated state and expression pattern of 24 repertoire TCR Vbeta of peripheral blood T lymphocytes in convalescence patients with severe acute respiratory syndrome (SARS)].[严重急性呼吸综合征(SARS)康复期患者外周血T淋巴细胞24种TCR Vβ库的亚群、活化状态及表达模式分析]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jan;21(1):114-7.
6
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.在多发性骨髓瘤患者的外周血中,CD4(+)CD25(+)FoxP3(+)调节性T细胞增加,而CD3(+)CD4(-)CD8(-)αβTCR(+)双阴性T细胞减少,这与疾病负担相关。
Br J Haematol. 2009 Mar;144(5):686-95. doi: 10.1111/j.1365-2141.2008.07530.x. Epub 2008 Dec 26.
7
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.意义未明的单克隆丙种球蛋白病与多发性骨髓瘤及浆细胞白血病中非整倍体模式的荧光原位杂交分析
Cancer. 2003 Feb 1;97(3):601-9. doi: 10.1002/cncr.11100.
8
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.意义未明的单克隆丙种球蛋白病患者浆细胞的免疫表型特征。对MGUS与多发性骨髓瘤鉴别诊断的意义。
Am J Pathol. 1998 Jun;152(6):1655-65.
9
In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.使用粒细胞集落刺激因子在体内诱导T细胞低反应性并改变骨髓移植免疫细胞
Haematologica. 2004 Dec;89(12):1517-24.
10
Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌患者外周血循环中CD8 + T淋巴细胞的T细胞受体可变β基因限制性图谱改变。
Clin Cancer Res. 2006 Apr 15;12(8):2394-403. doi: 10.1158/1078-0432.CCR-05-1818.

引用本文的文献

1
Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis.系统评价和荟萃分析:多发性骨髓瘤患者对 COVID-19 疫苗接种的免疫反应。
BMC Geriatr. 2024 May 8;24(1):411. doi: 10.1186/s12877-024-05006-0.
2
Role of Immune Cells and Immunotherapy in Multiple Myeloma.免疫细胞与免疫疗法在多发性骨髓瘤中的作用
Life (Basel). 2024 Apr 1;14(4):461. doi: 10.3390/life14040461.
3
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients.
多重免疫组化阐明了复发性骨髓瘤中细胞毒性 T 细胞和浆细胞之间距离的增加,并确定了 Lag-3 为骨髓瘤患者细胞毒性 T 细胞上最常见的检查点受体。
Haematologica. 2024 May 1;109(5):1487-1500. doi: 10.3324/haematol.2023.283344.
4
Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.在骨髓瘤患者中,PD-1 和 CTLA-4 检查点的异常表达在诊断时更为明显:对进展时间和治疗性检查点抑制剂反应的影响。
Int J Mol Sci. 2023 Mar 17;24(6):5730. doi: 10.3390/ijms24065730.
5
Case of Kikuchi-Fujimoto disease associated with multiple myeloma.菊池-藤本病合并多发性骨髓瘤 1 例
BMJ Case Rep. 2021 May 20;14(5):e241391. doi: 10.1136/bcr-2020-241391.
6
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression.多发性骨髓瘤中的免疫系统改变:逆转免疫抑制的分子机制与治疗策略
Cancers (Basel). 2021 Mar 17;13(6):1353. doi: 10.3390/cancers13061353.
7
Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention.多发性骨髓瘤中免疫反应的共同进化:对免疫预防的启示。
Front Immunol. 2021 Feb 26;12:632564. doi: 10.3389/fimmu.2021.632564. eCollection 2021.
8
Cytotoxic T Cell Responses Induced by CS1/CRT Fusion DNA Vaccine in a Human Plasmacytoma Model.CS1/CRT融合DNA疫苗在人浆细胞瘤模型中诱导的细胞毒性T细胞反应
Front Oncol. 2020 Nov 20;10:587237. doi: 10.3389/fonc.2020.587237. eCollection 2020.
9
Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview.基于当前对多发性骨髓瘤病理生物学的理解塑造治疗模式:概述
Cancers (Basel). 2020 Nov 23;12(11):3488. doi: 10.3390/cancers12113488.
10
Identification of the immune checkpoint signature of multiple myeloma using mass cytometry-based single-cell analysis.基于质谱流式细胞术的单细胞分析鉴定多发性骨髓瘤的免疫检查点特征
Clin Transl Immunology. 2020 Apr 29;9(5):e01132. doi: 10.1002/cti2.1132. eCollection 2020 May.